ML-14 LOW INVASIVE APPROACH FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA TREATMENT INVOLVING RITUXIMAB–METHOTREXATE + PROCARBAZINE + VINCRISTINE AND TRIPLE INTRATHECAL INJECTION

INTRODUCTION: Although the treatment outcomes of primary central nervous system lymphoma (PCNSL) with multiple treatment regimens involving high–dose methotrexate (MTX)–based multiagent chemotherapy have improved compared with the outcomes with high–dose methotrexate therapy in recent years, its reg...

Full description

Saved in:
Bibliographic Details
Published in:Neurooncol Adv
Main Authors: Ogawa, Takahiro, Oowada, Kei, Tanba, Kazuna, Hirakawa, Kouichi
Format: Artigo
Language:Inglês
Published: Oxford University Press 2019
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213455/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.156
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items